Significance of FAB subclassification of "acute myeloid leukemia, NOS" in the 2008 WHO classification: analysis of 5848 newly diagnosed patients.
about
Next generation sequencing: new tools in immunology and hematologyEasily manageable prognostic factors in 152 Chinese elderly acute myeloid leukemia patients: a single-center retrospective study.Clinical characteristics, outcome and early induction deaths in patients with acute promyelocytic leukaemia: a five-year experience at a tertiary care centreThe G⁵¹⁶T CYP2B6 germline polymorphism affects the risk of acute myeloid leukemia and is associated with specific chromosomal abnormalitiesBone marrow necrosis in acute leukemia: Clinical characteristic and outcome.The uniqueness of morphological features of pure erythroid leukemia in myeloid neoplasm with erythroid predominance: A reassessment using criteria revised in the 2016 World Health Organization classification.CDKN2B, SLC19A3 and DLEC1 promoter methylation alterations in the bone marrow of patients with acute myeloid leukemia during chemotherapyDiagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.Array comparative genomic hybridization in pediatric acute leukemias.How unique is pure erythroid leukaemia? A retrospective analysis of seven cases and review of the literature.Impact of FAB classification on predicting outcome in acute myeloid leukemia, not otherwise specified, patients undergoing allogeneic stem cell transplantation in CR1: An analysis of 1690 patients from the acute leukemia working party of EBMT.BCR-ABL-positive acute myeloid leukemia: a new entity? Analysis of clinical and molecular features.A Case of Acute Myeloid Leukemia (FAB M2) with Inversion 16 Who Presented with Pelvic Myeloid Sarcoma.Influence of BCL2-938C>A and BAX-248G>A promoter polymorphisms in the development of AML: case-control study from South India.Identification of miRNA-mRNA Network Associated with Acute Myeloid Leukemia SurvivalMissing the Benefit of Metformin in Acute Myeloid Leukemia: A Problem of Contrast?Flow cytometric maturity score as a novel prognostic parameter in patients with acute myeloid leukemia.Autoantibodies Against Carbonic Anhydrase I and II in Patients with Acute Myeloid Leukemia.A hospital based retrospective study of factors influencing therapeutic leukapheresis in patients presenting with hyperleukocytic leukaemia.Procoagulant activity of extracellular vesicles as a potential biomarker for risk of thrombosis and DIC in patients with acute leukaemia.Patients with acute myeloid leukemia can be subclassified based on the constitutive cytokine release of the leukemic cells; the possible clinical relevance and the importance of cellular iron metabolism.Mutations in the P10 region of procaspase-8 lead to chemotherapy resistance in acute myeloid leukemia by impairing procaspase-8 dimerization.Clinical manifestations and diagnosisDiagnostic criteria, classification, and prognosis of acute leukemias
P2860
Q27025231-67E426CE-EBF3-4608-A2F7-3298ABAF9676Q34340772-F1C0BB4B-0B50-4C5A-A2E5-B0D2B606F1B6Q34953881-E6E8A0C7-E199-4A97-9258-E506DFD81965Q35106387-CCD1605D-8A02-4904-8015-1E10FAACD1EEQ35987462-835E4635-9EA2-4A48-A358-8AFB9B5F70CDQ36279945-6D16C30C-4081-4553-8CA1-0EE391C13869Q36824910-E91C7522-9C2B-4293-8EB8-E5B66EE4CB2DQ37624593-009FAD04-26DA-4F7C-B78D-0C46564F61FDQ38113815-D4FAD718-E020-4D02-BF08-E3A8D2D9DA8BQ38327599-E16AB241-1761-4C1C-97C5-7D66AEEB5220Q39040937-198591C3-31D8-4B0D-98AE-C33BA65CBFEAQ39685853-1EDB818D-B32C-4F6E-8E5F-49DB9CA4DC1EQ40172961-B5631F8F-0DD1-4C61-B0E0-A8FC8AC9336DQ41750576-49484A61-A697-45F2-85C4-7C63A89C2330Q42267035-CEF94538-EF00-41D6-886F-94E5DB72D781Q42269875-A72A1E92-11C4-46CC-92ED-37DCB215B4F4Q47829263-F49F70DC-0581-4784-9561-A200EF9DDE3CQ47965507-EFF8DE92-190D-4D7E-A690-174398A640A0Q48267537-449980BC-0077-42A2-A9FC-24D902D3E6B4Q50959065-0677B4BB-C433-4009-91B1-20D350FE7AE5Q51102707-2247FF46-2BE4-47FE-A9AB-BE24D50FFD71Q55302326-E3537D77-0166-48BF-9B00-2026449EC78FQ57898941-450371C3-2DB0-4A3E-BCE9-31FE02B6EC90Q57898947-1800D971-C5A6-42F9-A319-97E8FFE70785
P2860
Significance of FAB subclassification of "acute myeloid leukemia, NOS" in the 2008 WHO classification: analysis of 5848 newly diagnosed patients.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Significance of FAB subclassif ...... 5848 newly diagnosed patients.
@ast
Significance of FAB subclassif ...... 5848 newly diagnosed patients.
@en
type
label
Significance of FAB subclassif ...... 5848 newly diagnosed patients.
@ast
Significance of FAB subclassif ...... 5848 newly diagnosed patients.
@en
prefLabel
Significance of FAB subclassif ...... 5848 newly diagnosed patients.
@ast
Significance of FAB subclassif ...... 5848 newly diagnosed patients.
@en
P2093
P2860
P50
P1433
P1476
Significance of FAB subclassif ...... 5848 newly diagnosed patients.
@en
P2093
Alan K Burnett
Anna Evans
Elihu H Estey
Gert J Ossenkoppele
Kees G M van Montfort
Robert K Hills
Roland B Walter
Sherry R Pierce
P2860
P304
P356
10.1182/BLOOD-2012-10-462440
P407
P577
2013-01-16T00:00:00Z